New cancer clinical trial: Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: (None)

Published on: February 27, 2018 at 12:00PM
Condition:   Non-Small Cell Lung Cancer
Interventions:   Drug: Canakinumab;   Drug: Placebo
Sponsor:   Novartis Pharmaceuticals
Not yet recruiting
http://ift.tt/2HOWXFU